Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat-containing protein 72 is a member of the leucine-rich repeat (LRR) superfamily of proteins characterized by tandem repeats containing conserved leucine residues. LRR domains function as versatile scaffolds enabling protein-protein interactions often involved in processes such as immune signaling, cell adhesion, neurodevelopment, and structural support. LRRC72 is a protein coding gene with limited functional annotation. Its expression has been associated with certain genetic conditions, including primary ciliary dyskinesia, but its biological role remains largely uncharacterized. LRRC72 is not currently known to serve as a receptor, enzyme, or transporter, and there are no drugs nor biomarkers associated with it. Most functional insights for LRR-containing proteins are derived from other family members, many of which play roles in innate immunity, cell signaling, or cytoskeletal organization. LRRC72 appears to be an "LRR-only" protein without additional annotated functional domains—this limits functional inference. There is no evidence in current literature of LRRC72 being a validated therapeutic target, clinical biomarker, or target of pharmacological agents. In summary: LRRC72 is a protein with leucine-rich repeats and limited known function. It is not a designated therapeutic target, is not misspelled, and lacks robust disease or drug associations as of current data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat-containing protein 72 (LRRC72).